AZN China President under investigation

This announcement contains inside information

30 October 2024

AstraZeneca China President currently under investigation

Leon Wang, Executive Vice President International and President of AstraZeneca China, is cooperating with an ongoing investigation by Chinese authorities.

Our China operations continue under the leadership of the current General Manager of AstraZeneca China.

AstraZeneca will fully cooperate with the investigation if requested.

AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-driven biopharmaceutical company focused on the discovery, development and commercialization of prescription drugs in Oncology, Rare Diseases and Biopharmaceuticals including Cardiovascular, Kidney and Metabolism and Respiratory. and Immunology. Headquartered in Cambridge, England, AstraZeneca’s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.

Contacts
Please click here for details on how to contact the Investor Relations Team. Click here for media contacts.

Adrian Kemp
Company Secretary
AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the UK. Terms and conditions governing the use and distribution of this information may apply. For more information, please contact [email protected] or visit www.rns.com.